CJC-1295 is a long-acting growth hormone-releasing hormone (GHRH) analog distinguished by its prolonged activity compared with native GHRH. Research has shown that CJC-1295 can produce sustained changes in growth hormone (GH) and insulin-like growth factor-1 (IGF-1) levels while preserving the pulsatile pattern of GH secretion. Research applications primarily focus on the GH/IGF-1 axis, growth hormone secretion dynamics, and the pharmacokinetic characteristics of long-acting GHRH analogs. As a research-grade API, product specifications and batch-specific quality documentation can be provided according to supply requirements.